JP2009501753A5 - - Google Patents

Download PDF

Info

Publication number
JP2009501753A5
JP2009501753A5 JP2008521908A JP2008521908A JP2009501753A5 JP 2009501753 A5 JP2009501753 A5 JP 2009501753A5 JP 2008521908 A JP2008521908 A JP 2008521908A JP 2008521908 A JP2008521908 A JP 2008521908A JP 2009501753 A5 JP2009501753 A5 JP 2009501753A5
Authority
JP
Japan
Prior art keywords
hydrogen
double bond
group
ethyl
alkyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2008521908A
Other languages
English (en)
Japanese (ja)
Other versions
JP5345843B2 (ja
JP2009501753A (ja
Filing date
Publication date
Priority claimed from EP05090214.7A external-priority patent/EP1746101B2/de
Application filed filed Critical
Priority claimed from PCT/EP2006/007287 external-priority patent/WO2007009821A1/en
Publication of JP2009501753A publication Critical patent/JP2009501753A/ja
Publication of JP2009501753A5 publication Critical patent/JP2009501753A5/ja
Application granted granted Critical
Publication of JP5345843B2 publication Critical patent/JP5345843B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2008521908A 2005-07-21 2006-07-20 17−(3−ヒドロキシプロピル)−3,17−ジヒドロキシアンドロスタンの無金属酸化による3−オキソ−プレグン−4−エン−21,17−カルボラクトンの生成方法 Active JP5345843B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP05090214.7A EP1746101B2 (de) 2005-07-21 2005-07-21 Verfahren zur Herstellung von 3-Oxo-pregn-4-en-21,17-carbolactonen durch die metallfreie Oxidation von 17-(3-hydroxypropyl)-3,17-dihydroxyandrostanen
EP05090214.7 2005-07-21
PCT/EP2006/007287 WO2007009821A1 (en) 2005-07-21 2006-07-20 Process for the production of 3-oxo-pregn-4-ene-21,17-carbolactones by the metal-free oxidation of 17-(3-hydroxypropyl)-3,17-dihydroxyandrostanes

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2013123726A Division JP2013177450A (ja) 2005-07-21 2013-06-12 17−(3−ヒドロキシプロピル)−3,17−ジヒドロキシアンドロスタンの無金属酸化による3−オキソ−プレグン−4−エン−21,17−カルボラクトンの生成方法

Publications (3)

Publication Number Publication Date
JP2009501753A JP2009501753A (ja) 2009-01-22
JP2009501753A5 true JP2009501753A5 (enExample) 2009-07-02
JP5345843B2 JP5345843B2 (ja) 2013-11-20

Family

ID=35744678

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2008521908A Active JP5345843B2 (ja) 2005-07-21 2006-07-20 17−(3−ヒドロキシプロピル)−3,17−ジヒドロキシアンドロスタンの無金属酸化による3−オキソ−プレグン−4−エン−21,17−カルボラクトンの生成方法
JP2013123726A Pending JP2013177450A (ja) 2005-07-21 2013-06-12 17−(3−ヒドロキシプロピル)−3,17−ジヒドロキシアンドロスタンの無金属酸化による3−オキソ−プレグン−4−エン−21,17−カルボラクトンの生成方法

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2013123726A Pending JP2013177450A (ja) 2005-07-21 2013-06-12 17−(3−ヒドロキシプロピル)−3,17−ジヒドロキシアンドロスタンの無金属酸化による3−オキソ−プレグン−4−エン−21,17−カルボラクトンの生成方法

Country Status (22)

Country Link
US (2) US20070049747A1 (enExample)
EP (1) EP1746101B2 (enExample)
JP (2) JP5345843B2 (enExample)
CN (1) CN101223186B (enExample)
AR (1) AR055993A1 (enExample)
AT (1) ATE403668T1 (enExample)
CY (1) CY1110411T1 (enExample)
DE (1) DE502005004948D1 (enExample)
DK (1) DK1746101T4 (enExample)
DO (1) DOP2006000172A (enExample)
ES (1) ES2311927T5 (enExample)
GT (1) GT200600321A (enExample)
MY (1) MY147795A (enExample)
PE (2) PE20070215A1 (enExample)
PL (1) PL1746101T5 (enExample)
PT (1) PT1746101E (enExample)
SI (1) SI1746101T2 (enExample)
SV (1) SV2007002621A (enExample)
TW (1) TWI392683B (enExample)
UA (1) UA100092C2 (enExample)
UY (1) UY29686A1 (enExample)
ZA (1) ZA200801674B (enExample)

Families Citing this family (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE502005004948D1 (de) * 2005-07-21 2008-09-18 Bayer Schering Pharma Ag Verfahren zur Herstellung von 3-Oxo-pregn-4-en-21,17-carbolactonen durch die metallfreie Oxidation von 17-(3-hydroxypropyl)-3,17-dihydroxyandrostanen
WO2009111574A2 (en) * 2008-03-05 2009-09-11 Evestra, Inc. BISMETHYLENE-17α CARBOLACTONES AND RELATED USES
DE102008026793A1 (de) * 2008-06-02 2009-12-03 Bayer Schering Pharma Aktiengesellschaft C-Ring-substituierte Pregn-4-en-21,17-carbolactone, sowie diese enthaltende pharmazeutische Präparate
WO2010068500A2 (en) * 2008-11-25 2010-06-17 Evestra, Inc. PROGESTATIONAL 3-(6,6-ETHYLENE-17b-HYDROXY-3-OXO-17a-PREGNA-4-ENE-17a -YL) PROPIONIC ACID g-LACTONES
US8334375B2 (en) * 2009-04-10 2012-12-18 Evestra, Inc. Methods for the preparation of drospirenone
ES2432063T3 (es) 2009-06-16 2013-11-29 Crystal Pharma, S.A.U. Procedimiento para la obtención de 17-espirolactonas en esteroides
CN101775057B (zh) * 2010-02-09 2014-07-16 浙江仙琚制药股份有限公司 屈螺酮及其中间体的制备方法
CN101830959B (zh) * 2010-05-27 2012-07-18 杭州龙山化工有限公司 一种曲螺酮的合成方法
AR081670A1 (es) 2010-06-29 2012-10-10 Leon Farma Sa Lab Composicion farmaceutica que comprende drospirenona y kit anticonceptivo
US11351122B1 (en) 2010-07-28 2022-06-07 Laboratorios Leon Farma Sa Synthetic progestogens and pharmaceutical compositions comprising the same
US10849857B2 (en) 2010-07-28 2020-12-01 Laboratorios Leon Farma Sa Pharmaceutical compositions comprising active drugs, contraceptive kits comprising active drugs, and methods of administering the same
WO2012107513A1 (en) 2011-02-10 2012-08-16 Crystal Pharma, S.A.U. Process for obtaining drospirenone
CN102746370A (zh) * 2011-04-22 2012-10-24 天津金耀集团有限公司 一种氧化合成孕甾11位酮基的新工艺
AU2012365511B2 (en) * 2012-01-13 2016-07-14 Saint-Gobain Glass France Spacer for insulating glazing units
CN102887934B (zh) * 2012-09-20 2015-05-27 杭州福斯特药业有限公司 一种屈螺酮的制备方法
HUE032858T2 (en) * 2013-04-12 2017-11-28 Ind Chimica Srl Method for producing drospirenone
CN104163846A (zh) * 2013-05-17 2014-11-26 上海创诺制药有限公司 一种制备曲螺酮的方法
US10167665B2 (en) 2013-12-12 2019-01-01 Saint-Gobain Glass France Spacer for insulating glazing units, comprising extruded profiled seal
US10190359B2 (en) 2013-12-12 2019-01-29 Saint-Gobain Glass France Double glazing having improved sealing
CN104788524B (zh) * 2014-01-16 2016-07-06 浙江仙居君业药业有限公司 一种19-去甲-4-雄甾烯-3,17-二酮的制备方法
TR201815606T4 (tr) 2014-06-27 2018-11-21 Saint Gobain Mesafe parçasına sahip yalıtım cam kaplaması ve bunun imal edilmesi için yöntem ve ayrıca bunun bina cam kaplaması olarak kullanımı.
WO2015197491A1 (de) 2014-06-27 2015-12-30 Saint-Gobain Glass France Isolierverglasung mit abstandhalter und verfahren zur herstellung
US10626663B2 (en) 2014-09-25 2020-04-21 Saint-Gobain Glass France Spacer for insulating glazing units
DK3265636T3 (da) 2015-03-02 2022-05-23 Saint Gobain Glasfiberforstærket afstandsholder til isoleringsrude, fremgangsmåde til fremstilling af denne og anvendelse af en sådan afstandsholder i flerlagsruder
EP3108889A1 (en) 2015-06-23 2016-12-28 Philippe Perrin Drospirenone-based contraceptive for a female patient affected with excess weight
LT3313408T (lt) 2015-06-23 2024-03-12 Laboratorios Leon Farma Sa Kontraceptikas drospirenono pagrindu, skirtas pacientėms, turinčioms antsvorio

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4069219A (en) 1976-12-27 1978-01-17 G. D. Searle & Co. 7ξ-(Alkoxycarbonyl)-6ξ-alkyl/halo-17-hydroxy-3-oxo-17α-pregn-4-ene-21-carboxylic acid γ-lactones and corresponding 21-carboxylic acids, their salts, and esters
DE3026783C2 (de) 1980-07-11 1982-07-29 Schering Ag, 1000 Berlin Und 4619 Bergkamen Verfahren zur Herstellung von 5β-Hydroxy-δ↑6↑-steroiden
DE3042136A1 (de) 1980-11-03 1982-06-09 Schering Ag, 1000 Berlin Und 4619 Bergkamen Verfahren zur herstellung von 3 (beta), 7 (beta) -dihydroxy- (delta) (pfeil hoch)5(pfeil hoch) -steroiden
ATE15206T1 (de) 1981-09-21 1985-09-15 Schering Ag 3-beta,7-beta,15-alpha-trihydroxy-5-androsten-1 - one, ihre 3,15-trimethylessigsaeure-ester und ihre herstellung.
US5106995A (en) 1989-05-05 1992-04-21 Isp Investments Inc. Production of lactones from diols
DE3916112A1 (de) * 1989-05-16 1990-11-22 Schering Ag Dihydrospirorenon als antiandrogen
DE19633685C1 (de) * 1996-08-12 1997-10-09 Schering Ag Verfahren zur Herstellung von Drospirenon (6beta,7beta;15 beta,16beta-Dimethyl-en-3-oxo-17alpha-pregn-4-en-21,17-carbolacton, DRSP) sowie 7alpha-(3-Hydroxy-1-propyl)-6beta,7beta;15beta, 16beta-dimethylen-5beta-androstan-3beta,5,17beta-triol (ZK 92836) und 6beta,7beta;15beta,16beta-dimethylen-5beta-hydroxy-3-oxo-17alpha-androstan-21,17-carbolacton (90965) als Zwischenprodukte des Verfahrens
EP1534732B1 (en) * 2002-08-16 2006-09-13 Pharmacia & Upjohn Company LLC 5 androsten-3-ol steroid intermediates and processes for their preparation
JP2005027184A (ja) * 2003-07-04 2005-01-27 Seiko Epson Corp 高周波複合部品
ITMI20040367A1 (it) 2004-03-01 2004-06-01 Ind Chimica Srl Processo per la preparazione di drospirenone
ITMI20042338A1 (it) * 2004-12-06 2005-03-06 Ind Chimica Srl Processo per la preparazione di drospirenone
DE502005004948D1 (de) * 2005-07-21 2008-09-18 Bayer Schering Pharma Ag Verfahren zur Herstellung von 3-Oxo-pregn-4-en-21,17-carbolactonen durch die metallfreie Oxidation von 17-(3-hydroxypropyl)-3,17-dihydroxyandrostanen
US7319154B2 (en) * 2005-07-21 2008-01-15 Bayer Schering Pharma Ag Process for the production of 3-oxo-pregn-4-ene-21, 17-carbolactones by the metal free oxidation of 17-(3-hydroxypropyl)-3, 17-dihydroxyandrostanes
US20080032147A1 (en) * 2005-08-26 2008-02-07 Thomas Neel Medium density fibreboard

Similar Documents

Publication Publication Date Title
JP2009501753A5 (enExample)
JP2008518890A5 (enExample)
EP2592070A3 (en) Tetrazole-substituted arylamides
JP2007302689A5 (enExample)
AR062504A1 (es) Procedimientos para preparar acidos d,l-2hidroxi-4-alquiltiobutiricos
JP2004536811A5 (enExample)
JP2010536766A5 (enExample)
JP2006526031A5 (enExample)
JP2007500753A5 (enExample)
EP2102898A4 (en) REEL TO REEL REACTION OF A PRECURSOR FOIL FOR FORMING A SOLAR CELL ABSORPTION LAYER
JP2006519232A5 (enExample)
JP2010090366A5 (enExample)
MX2009004900A (es) Arilamidas sustituidas por tiazol u oxazol.
JP2009520765A5 (enExample)
JP2008212853A5 (enExample)
JP2009538336A5 (enExample)
JP2007519721A5 (enExample)
JP2011508779A5 (enExample)
PT1874762E (pt) Processo para a produção de 5-(4-[4-(5-ciano-3-indolil)- butil]-1-piperazinil)-benzofurano-2-carboxamida
JP2008520662A5 (enExample)
JP2010510263A5 (enExample)
JP2008514558A5 (enExample)
JP2010517998A5 (enExample)
WO2008008327A3 (en) Xinafoate salt of a substituted 5-oxazol-2-yl-quinoline compound
NZ599218A (en) Process for the manufacture of organic compounds